Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Lukas Zell, Alina Bretl, Veronika Temml & Daniela Schuster. (2023) Dopamine Receptor Ligand Selectivity—An In Silico/In Vitro Insight. Biomedicines 11:5, pages 1468.
Crossref
Crossref
Beatriz Bueschbell, Pedro R. Magalhães, Carlos A.V. Barreto, Rita Melo, Anke C. Schiedel, Miguel Machuqueiro & Irina S. Moreira. (2023) The World of GPCR dimers – Mapping dopamine receptor D2 homodimers in different activation states and configuration arrangements. Computational and Structural Biotechnology Journal 21, pages 4336-4353.
Crossref
Crossref
Lukas Zell, Constanze Lainer, Jakub Kollár, Veronika Temml & Daniela Schuster. (2022) Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach. Molecules 27:14, pages 4435.
Crossref
Crossref
Abhinanda Chowdhury & Prashant Chandra Singh. (2022) Role of the weak noncovalent interactions in the stability of the aggregated protonated dopamine in the aqueous solution: spectroscopic and quantum chemical calculation studies. Journal of Chemical Sciences 134:1.
Crossref
Crossref
Yao Liu, Chun Kit K. Choi, Huiling Hong, Yu Xiao, Man Long Kwok, Hanzhuang Liu, Xiao Yu Tian & Chung Hang Jonathan Choi. (2021) Dopamine Receptor-Mediated Binding and Cellular Uptake of Polydopamine-Coated Nanoparticles. ACS Nano 15:8, pages 13871-13890.
Crossref
Crossref
Luyu Fan, Liang Tan, Zhangcheng Chen, Jianzhong Qi, Fen Nie, Zhipu Luo, Jianjun Cheng & Sheng Wang. (2020) Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands. Nature Communications 11:1.
Crossref
Crossref
Rafał Kurczab, Katarzyna Kucwaj-Brysz & Paweł Śliwa. (2019) The Significance of Halogen Bonding in Ligand–Receptor Interactions: The Lesson Learned from Molecular Dynamic Simulations of the D4 Receptor. Molecules 25:1, pages 91.
Crossref
Crossref
Yong Xu, Yongbin Hu, Pei Feng, Wenjin Yang & Cijun Shuai. (2019) Drug loading/release and bioactivity research of a mesoporous bioactive glass/polymer scaffold. Ceramics International 45:14, pages 18003-18013.
Crossref
Crossref
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration
1
39
.
Beatriz Bueschbell, Carlos Barreto, António Preto, Anke Schiedel & Irina Moreira. (2019) A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods. Molecules 24:7, pages 1196.
Crossref
Crossref
Debra Boyd-Kimball, Katelyn Gonczy, Benjamin Lewis, Thomas Mason, Nicole Siliko & Jacob Wolfe. (2018) Classics in Chemical Neuroscience: Chlorpromazine. ACS Chemical Neuroscience 10:1, pages 79-88.
Crossref
Crossref
Tadashi Nishikawa, Yoichiro Araki & Teruo Hayashi. (2015) Intractable hiccups (singultus) abolished by risperidone, but not by haloperidol. Annals of General Psychiatry 14:1.
Crossref
Crossref
Marcello Leopoldo, Svetlana V. Selivanova, Adrienne Müller, Enza Lacivita, John A. Schetz & Simon M. Ametamey. (2014)
In Vitro
and
In Vivo
Evaluation of
N
‐{2‐[4‐(3‐Cyanopyridin‐2‐yl)piperazin‐1‐yl]ethyl}‐3‐[
11
C]methoxybenzamide, a Positron Emission Tomography (PET) Radioligand for Dopamine D
4
Receptors, in Rodents
. Chemistry & Biodiversity 11:9, pages 1298-1308.
Crossref
Crossref
Jan-Peter van Wieringen, Vladimir Shalgunov, Henk M. Janssen, P. Michel Fransen, Anton G. M. Janssen, Martin C. Michel, Jan Booij & Philip H. Elsinga. (2014)
Synthesis and Characterization of a Novel Series of Agonist Compounds as Potential Radiopharmaceuticals for Imaging Dopamine D
2/3
Receptors in Their High-Affinity State
. Journal of Medicinal Chemistry 57:2, pages 391-410.
Crossref
Crossref
Spencer S. Ericksen, David F. Cummings, Michael E. Teer, Shahnawaz Amdani & John A. Schetz. (2012) Ring Substituents on Substituted Benzamide Ligands Indirectly Mediate Interactions with Position 7.39 of Transmembrane Helix 7 of the D4 Dopamine Receptor. Journal of Pharmacology and Experimental Therapeutics 342:2, pages 472-485.
Crossref
Crossref
Mattis B. Wigestrand, Frode Fonnum & S. Ivar Walaas. (2012) Subunit-specific modulation of [3H]MK-801 binding to NMDA receptors mediated by dopamine receptor ligands in rodent brain. Neurochemistry International 61:2, pages 266-276.
Crossref
Crossref
Ethan B. Van Arnam, Henry A. Lester & Dennis A. Dougherty. (2011) Dissecting the Functions of Conserved Prolines within Transmembrane Helices of the D2 Dopamine Receptor. ACS Chemical Biology 6:10, pages 1063-1068.
Crossref
Crossref
Kristoffer Sahlholm, Ofra Barchad-Avitzur, Daniel Marcellino, Maricel Gómez-Soler, Kjell Fuxe, Francisco Ciruela & Peter Århem. (2011) Agonist-specific voltage sensitivity at the dopamine D2S receptor – Molecular determinants and relevance to therapeutic ligands. Neuropharmacology 61:5-6, pages 937-949.
Crossref
Crossref
David F. Cummings, Diana C. Canseco, Pratikkumar Sheth, James E. Johnson & John A. Schetz. (2010) Synthesis and structure?affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes. Bioorganic & Medicinal Chemistry 18:13, pages 4783-4792.
Crossref
Crossref
David F. Cummings, Spencer S. Ericksen, Angela Goetz & John A. Schetz. (2010) Transmembrane Segment Five Serines of the D4 Dopamine Receptor Uniquely Influence the Interactions of Dopamine, Norepinephrine, and Ro10-4548. Journal of Pharmacology and Experimental Therapeutics 333:3, pages 682-695.
Crossref
Crossref
Nuska Tschammer, Miriam Dörfler, Harald Hübner & Peter Gmeiner. (2009)
Engineering a GPCR−Ligand Pair That Simulates the Activation of D
2L
by Dopamine
. ACS Chemical Neuroscience 1:1, pages 25-35.
Crossref
Crossref
David F. Cummings, Spencer S. Ericksen & John A. Schetz. (2009)
Three amino acids in the D
2
dopamine receptor regulate selective ligand function and affinity
. Journal of Neurochemistry 110:1, pages 45-57.
Crossref
Crossref
Spencer S. Ericksen, David F. Cummings, Harel Weinstein & John A. Schetz. (2009)
Ligand Selectivity of D
2
Dopamine Receptors Is Modulated by Changes in Local Dynamics Produced by Sodium Binding
. Journal of Pharmacology and Experimental Therapeutics 328:1, pages 40-54.
Crossref
Crossref
Kristoffer Sahlholm, Daniel Marcellino, Johanna Nilsson, Kjell Fuxe & Peter Århem. (2008) Voltage-sensitivity at the human dopamine D2S receptor is agonist-specific. Biochemical and Biophysical Research Communications 377:4, pages 1216-1221.
Crossref
Crossref
John A. Schetz & David R. Sibley. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Changhai Cui, Ming Xu & Marco Atzori. (2006)
Voltage-Dependent Block of
N
-Methyl-D-aspartate Receptors by Dopamine D1 Receptor Ligands
. Molecular Pharmacology 70:5, pages 1761-1770.
Crossref
Crossref
Frank Boeckler & Peter Gmeiner. (2006) The structural evolution of dopamine D3 receptor ligands: Structure–activity relationships and selected neuropharmacological aspects. Pharmacology & Therapeutics 112:1, pages 281-333.
Crossref
Crossref
Samuel J. Clarke, C. Annette Hollmann, Zhijun Zhang, Diana Suffern, Stephen E. Bradforth, Nada M. Dimitrijevic, William G. Minarik & Jay L. Nadeau. (2006) Photophysics of dopamine-modified quantum dots and effects on biological systems. Nature Materials 5:5, pages 409-417.
Crossref
Crossref
Gabriella Ortore, Tiziano Tuccinardi, Simone Bertini & Adriano Martinelli. (2006) A Theoretical Study To Investigate D2DAR/D4DAR Selectivity: Receptor Modeling and Molecular Docking of Dopaminergic Ligands. Journal of Medicinal Chemistry 49:4, pages 1397-1407.
Crossref
Crossref
Christina Z. Floresca, Shiuhwei Chen, Sandhya Kortagere & John A. Schetz. (2005)
Reciprocal Mutations in TM2/TM3 in a D2 Dopamine Receptor Background Confirms the Importance of this Microdomain as a Selective Determinant of
Para
‐Halogenated 1,4‐Disubstituted Aromatic Piperazines
. Archiv der Pharmazie 338:5-6, pages 268-275.
Crossref
Crossref